Sinntaxis Overview
- Headquarters
- Lund, Skåne Län, Se
- Website
- www.sinntaxis.com
- Industry
- Public Health
- Employees
- 1
- Founded
- 2017
- NAICS
-
Administration of Public Health Programs
About Sinntaxis
Sinntaxis was founded 2017 by scientists at Lund University and LU Holding AB. The company is managed by a team with experience in neuroscience/stroke research, pharmaceutical drug development and business development. Sinntaxis has an established discovery platform for preclinical studies of stroke recovery, and has filed IP on the use of negative allosteric modulators of the metabotropic glutamate receptor 5 for the treatment of stroke recovery. Sinntaxis has established a global network of Key Opinion Leaders ranging from experimental research to clinical trial in stroke recovery.
Compare Similar Companies to Sinntaxis
Addex Therapeutics
Biotechnology Research
SynAct Pharma
Biotechnology Research
PILA PHARMA
Biotechnology Research
Stayble Therapeutics
Pharmaceutical Manufacturing
ApoGlyx
Biotechnology Research
Swedish Biomimetics 3000 μLOT Technology
Biotechnology Research
WntResearch AB
Biotechnology Research
Sensidose
Medical Equipment Manufacturing
Sinntaxis AB
Public Health
Targinta AB
Biotechnology Research